Association Between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis

    March 2022 in “ Healthcare ”
    Jean Kim, Kyle Miyazaki, Parthav Shah, Landon Kozai, Jakrin Kewcharoen
    TLDR Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.
    This systematic review and meta-analysis examined the association between mineralocorticoid receptor antagonist (MRA) therapy and mortality in SARS-CoV-2 patients, involving 1,388,178 subjects, with 80,903 receiving MRA therapy. The study found no significant reduction in mortality associated with MRA therapy, with an odds ratio of 0.387 and a 95% confidence interval of 0.134–1.117 (p = 0.079). Despite MRAs' potential protective effects against tissue fibrosis and inflammation, the results did not support a beneficial impact on mortality rates in COVID-19 patients. The study emphasized the need for larger-scale randomized controlled trials to further explore this relationship.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 6 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  41 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community When someone posts a scalp tension theory

      in Satire  265 upvotes 4 years ago
      Hair loss theories discussed include poor blood flow, scalp tension, inflammation, and DHT. Treatments mentioned are massaging scalp, minoxidil, finasteride, and RU58841.

      community Group Buy for MR antagonist finerenone

      in Product  11 upvotes 2 years ago
      User discusses group buy for finerenone, a third-gen mineralocorticoid antagonist for hair loss treatment. Finerenone inhibits TGFb, NOX, and ROS, and improves renal and cardiac function; topical dose should be no more than 10mg per day.

      community Dutasteride is amazing even for women with FAGA!

      in Female  151 upvotes 4 months ago
      Dutasteride significantly improved hair health and reduced shedding for a woman with PCOS and hyperandrogenism, without causing depression or anxiety, unlike finasteride. Dutasteride also helped with PMDD symptoms and had no side effects, though it changed hair texture.

      community risks with finasteride and dutasteride

      in Research/Science  144 upvotes 5 months ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

    Similar Research

    5 / 447 results